This paper addresses fecal microbiota transplantation (FMT) as a potential therapeutic approach for Parkinson's disease, focusing on the gut–brain axis but provides no abstract or concrete data in the submission.

Microbiome modulation is a plausible, translationally relevant avenue for PD (gut–brain interactions, inflammation, metabolism), but the lack of accessible data or mechanistic/clinical detail limits immediate utility for therapeutic discovery.